et al, 1997) . This has led to interest in finding a method for measuring tumour radiosensitivity that is applicable for widespread clinical use. The immunohistochemical analysis of DNA repair enzymes involved in the recognition or repair of radiationinduced DNA damage may have potential as a predictive assay of tumour radiosensitivity. In support of this, we have already shown that the expression of the human endonuclease HAPI correlates with the radiation sensitivity of human cervix tumours (Herring et al, 1998) . In this study we have examined the possible role of Ku protein in determining tumour radiosensitivity and response to radiotherapy.
MATERIALS AND METHODS

Immunohistochemistry of Ku70 and Ku80
Formalin-fixed, paraffin embedded sections (4 µm thick) were dewaxed for 10 min in xylene and rehydrated by passage through a graded ethanol series to tap water. Endogenous peroxidases were blocked with 3% hydrogen peroxide in Tris buffered saline (TBS) for 20 min. After washing in TBS for 5 min, the sections were blocked for a further 30 min using 10% normal swine serum (Dako) in TBS. Serum was removed by tapping and 100 µ1 of antibody or TBS for control sections was added. Anti-Ku70 and -Ku80 rabbit polyclonal antisera were raised against bacterially expressed full length human Ku70 or Ku80. They were used as 1:500 and 1:1000 dilutions in TBS, respectively. After incubation at 4˚C for 18 hours in TBS, the sections were washed 3 times in TBS for 5 min and incubated at room temperature for 30 min with 100 µ1 of biotinylated swine anti-rabbit IgG heavy chain and light chain antiserum (SARBO, Dako) at 1:400 in TBS. The sections were then washed 3 times in TBS for 5 min and incubated for 30 min at room temperature with 100 µ1 biotinylated peroxidasestreptavidin complex (ABC, Dako). Following three 5 min washes in TBS, the sections were stained for 5 min with 100 µl DAB (1 fast-DAB tablet (Sigma) dissolved in 20 ml TBS plus 10 µl 30% H 2 O 2 ). The DAB was removed and the sections washed in running tap water for 10 min and counterstained in Gills haemotoxylin for 1 min and blue alkali for 1 min. The sections were then dehydrated through the graded ethanol series to xylene and mounted.
Quantification of Ku70 and Ku80 expression in tumour sections using light microscopy
The number of cells in tumour samples stained positive for Ku70 and Ku80 was determined by scoring ten microscope fields of 100 tumour cells, without prior knowledge of radiosensitivity and treatment outcome, and determining the percentage of cells positive for Ku70 and Ku80 expression. The values are expressed as mean percentages of the 10 fields plus or minus the standard error of the mean.
Tumour radiosensitivity
The study was performed following South Manchester Medical Research Ethics Committee approval. The patient details, treatment protocols and assay methods are described elsewhere (West et al, 1997) . Briefly, all patients had bulky advanced disease and received radiotherapy with curative intent. Small volume disease was treated with intracavitary low-dose rate caesium alone. Remaining patients either received external beam irradiation (16 2 Gy fractions in 3 weeks) followed by two intracavitary caesium insertions or external beam over 4 weeks supplemented by a single low-dose rate intracavitary insertion. Random cervical punch biopsies were taken prior to initiation of treatment. Radiosensitivity was determined in vitro using a soft agar clonogenic assay as sensitivity to a single dose of 2 Gy radiation (SF2). Follow-up schedules of 3 monthly in the first 2 years, 4 monthly in the third year and 6 monthly for the next 2 years were employed. Local recurrence within the radiation field was confirmed histologically and/or using radiological techniques. Disease-specific survival was measured with minimum and median follow-up times of 24 and 58 months, respectively.
DATA ANALYSIS
The SPSS statistical software program was used to test for correlations between quantitative variables by the establishment of nonparametric linear regression. The probabilities of overall survival and local control was determined using univariable log-rank analysis, with the variables grouped into two (above and below median values) bands. As group boundaries correspond to medians, values falling on the boundaries meant that, in practice, the data subsets were not always exactly the same size. A significance level of 0.05 was used throughout.
RESULTS
The specificity of the antibodies was investigated in western blots of human whole cell extracts, where the Ku70 antibody recognized a single 70 kDa protein, and the Ku80 antibody recognized a single 80 kDa protein. Tris buffered saline (TBS) was used as a negative control. No staining was seen in any of the sections when TBS was used. Staining for Ku70 and Ku80 was predominantly nuclear.
To determine whether the scoring was reproducible, the 77 sections were scored blind twice and a t-test performed on the data. There was no significant difference between the percentage of cells stained positive for the proteins in the two data sets. Also the repeat scoring results were highly correlated for both Ku70 (r = 0.96, P < 0.001) and Ku80 (r = 0.98, P = 0.001). In order to examine inter-observer reproducibility, 12 sections were scored independently by another individual (CMLW). There was a significant correlation between the percentage of cells scored positive for both Ku70 (r = 0.74, P = 0.006) and Ku80 (r = 0.62, P = 0.031).
The percentage of cells expressing Ku70 and Ku80 in different tumours ranged from 0-95% for both (Table 1) . Several of the sections exhibited pronounced intercellular variation in staining for Ku70 and Ku80 and a similar pattern of staining for both Ku70 and Ku80 could be seen in the individual sections. There was a high degree of correlation between the percentage of cells expressing Ku70 and Ku80 in the tumour sections and 11 of the 77 tumours had a low number of cells expressing Ku proteins (Figure 1 ). For some of the tumours data were available for mitotic (n = 37) and Ki67 (n = 25) index. There were no correlations between tumour SF2 values were available for 53 of the tumour samples (West et al, 1997 ) and these ranged from 0.14 to 0.91 with a median value of 0.42 (Table 1 ). There was a borderline significant correlation between intrinsic sensitivity to ionizing radiation and Ku70 expression (r = 0.26, P = 0.057) but no relationship for Ku80 (r = 0.18, P = 0.19). These relationships are illustrated in Figure 2 and show that tumours with high SF2 value (i.e., radioresistant tumours with SF2 > 0.60) all had a high percentage of Ku positive cells. Table 2 summarizes the distribution of patients regarding disease stage, tumour grade and histology. The median age for the 77 patients was 55 years (range 29-79 years). Relationships were examined between Ku expression and the clinical parameters listed in Table 2 . No significant relationships were seen. Log-rank analysis was performed to determine whether Ku70 or Ku80 expression could be used as prognostic indicators for the response of cervical carcinoma patients to radiotherapy (Figure 3) . Survival levels for patients with tumours with high versus low Ku70 were 47% and 69%, respectively (Table 3) . The difference reached statistical significance (P = 0.046). There was also a higher level of survival for patients whose tumours had a below median percentage of Ku80 positive cells (69%) as opposed to those with higher than median level (50%), but the differences did not reach statistical significance (P = 0.087). Similar relationships were seen for local control but these also did not reach statistical significance (Figure 4) . Table 3 summarizes the outcome data for Ku70, Ku80, SF2, age and stage for the patients included in the study. Although, there were insufficient patient numbers for a multivariate analysis, bivariable analyses were carried out. Borderline significant correlations were seen after allowing for age and stage but the prognostic significance of Ku expression was lost after allowing for SF2. Also while there appeared to be no stage-dependent effect, there was for age. Tumour Ku expression was not important for young women, below the median age. However, for older women there was a large difference in survival for both Ku70 (P = 0.040) and Ku80 (P = 0.0034). 
DISCUSSION
Staining for Ku70 and Ku80 in all the cervix tumours studied was predominantly nuclear as expected from previous reports using direct immunofluorescence (Higashiura et al, 1992; Hong et al, 1994) . There was a high degree of intratumour heterogeneity in Ku expression. This is unlikely to result from heterogeneity in cell cycle phase distribution for several reasons. First, Ku has been shown to remain in the nucleus throughout the cell cycle (Yaneva and Jhiang, 1991) . Second, no correlation was seen between Ku70 or Ku80 expression and tumour proliferation measured as either mitotic or Ki67 index. Also, there was a good correlation between the number of cells in tumour samples stained positive for Ku70 and Ku80 that supports in vitro studies of the interdependence of the two heterodimer components (Satoh et al, 1995) . The latter suggests that intratumour heterogeneity in Ku expression is not a staining artefact. In a study from which the cohort of patients studied here was taken, tumour SF2 has been shown to be a highly significant prognostic factor for cervical carcinoma undergoing radiotherapy (West et al, 1997 . SF2 is a measure of the intrinsic radiosensitivity of cells. As described earlier, there is ample evidence for a role of Ku in determining cellular response to radiation. However, no significant correlation was found between SF2 and the expression of Ku70 or Ku80. A similar lack of correlation between SF2 and DNA-PK activity has been shown, albeit in cell lines derived from 9 malignant gliomas (Allalunis-Turner et al, 1995) . Others have shown that, in comparison with radioresistant lines, some radiosensitive tumour cell lines have less DNA-PK activity (Polischouk et al, 1999; Sirzen et al, 1999) . There has been one other study using human tumours where SF2 has been measured as described here (Bjork Eriksson et al, 1999) . The latter study, on head and neck tumours, also showed no significant correlation between SF2 and either DNA-PKcs (r = 0.22, P = 0.081) or Ku (p70/p80) (r = 0.064, P = 0.62) expression in 64 tumours. However, in both the latter study and ours, tumours with a low percentage of Ku or DNA-PK cs positive cells were all sensitive, with low SF2 values. This suggests that loss of Ku expression may account for the radiosensitivity of some tumours. However, the radiosensitivity of tumours with a high percentage of Ku positive cells may be due to the mutation or down-regulation of other DNA-damage sensing or repair proteins. Alternatively/additionally the lack of correlation seen may be because studies using primary human tumours or early passage cell lines assessing radiosensitivity using clonogenic assays will analyse a sub-population of cells whilst immunohistochemical staining/cell extract measurements are performed on the total tumour population. There may also be cell type-dependent differences.
A link between Ku expression and ionizing radiation sensitivity is further supported by the significantly higher survival for patients whose tumours had a low percentage of Ku70 positive cells (P = 0.046). The difference in patient outcome was also reflected with Ku80, but did not reach significance (P = 0.086). The poorer prognosis of patients with high Ku70 expression suggests that tumour cells with the ability to repair damaged DNA are more likely to survive and proliferate following treatment.
Interest in measuring radiosensitivity lies not only in tumours but also normal tissues . Therefore, it would be useful to examine the relationship between tumour and normal tissue expression levels of Ku proteins. No relationship was seen between DNA-PK mRNA levels/activity in a group of human fibroblast lines (Kasten et al, 1999) . In addition, a recent study has shown that acquired radioresistance in a murine cell line was associated with an increase in Ku activity (Frit et al, 1999) . It may be that the high levels of Ku protein seen in most of the tumours studied here are an acquired phenotype. In order to test this, parallel samples of tumour and normal tissue should be taken from patients.
In conclusion, despite reports of changes in radiosensitivity when Ku levels are markedly altered, no significant correlation was seen between tumour Ku protein expression and in vitro radiosensitivity. However, there was a wide variation in the degree of antibody staining between tumours and all tumours with a low percentage of Ku positive cells were radiosensitive. In addition, we have shown that expression of Ku70 in human cervix carcinoma is prognostic for survival for patients undergoing radiotherapy. This finding suggests that DNA-PK is involved in determining cancer outcome via its involvement in DNA dsb repair but other factors are also important. It is likely that the most accurate prediction of treatment outcome will lie in assessing the expression of several proteins involved in the recognition and repair of DNA damage, one of which will be Ku.
